nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—HTR2C—metabolic syndrome X	0.77	1	CbGaD
Ergotamine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00971	0.124	CbGeAlD
Ergotamine—HTR2A—arteriole—metabolic syndrome X	0.00916	0.117	CbGeAlD
Ergotamine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00653	0.0832	CbGeAlD
Ergotamine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00584	0.0744	CbGeAlD
Ergotamine—HTR1B—artery—metabolic syndrome X	0.00463	0.059	CbGeAlD
Ergotamine—HTR1D—artery—metabolic syndrome X	0.00448	0.0571	CbGeAlD
Ergotamine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00393	0.05	CbGeAlD
Ergotamine—HTR1B—blood vessel—metabolic syndrome X	0.0036	0.0459	CbGeAlD
Ergotamine—HTR1D—blood vessel—metabolic syndrome X	0.00349	0.0445	CbGeAlD
Ergotamine—HTR2A—artery—metabolic syndrome X	0.00223	0.0284	CbGeAlD
Ergotamine—Ergonovine—HTR2C—metabolic syndrome X	0.00216	0.268	CrCbGaD
Ergotamine—ADRA1B—kidney—metabolic syndrome X	0.00208	0.0265	CbGeAlD
Ergotamine—Methylergometrine—HTR2C—metabolic syndrome X	0.00189	0.234	CrCbGaD
Ergotamine—HTR2A—endothelium—metabolic syndrome X	0.00188	0.024	CbGeAlD
Ergotamine—HTR2A—blood vessel—metabolic syndrome X	0.00173	0.0221	CbGeAlD
Ergotamine—HTR1B—cardiovascular system—metabolic syndrome X	0.00161	0.0205	CbGeAlD
Ergotamine—Methysergide—HTR2C—metabolic syndrome X	0.00157	0.195	CrCbGaD
Ergotamine—HTR1D—cardiovascular system—metabolic syndrome X	0.00156	0.0198	CbGeAlD
Ergotamine—HTR1D—kidney—metabolic syndrome X	0.00152	0.0194	CbGeAlD
Ergotamine—HTR2B—cardiovascular system—metabolic syndrome X	0.00145	0.0185	CbGeAlD
Ergotamine—HTR1A—cardiovascular system—metabolic syndrome X	0.0013	0.0165	CbGeAlD
Ergotamine—HTR2B—adipose tissue—metabolic syndrome X	0.00128	0.0163	CbGeAlD
Ergotamine—Lisuride—HTR2C—metabolic syndrome X	0.00126	0.157	CrCbGaD
Ergotamine—ADRA1A—cardiovascular system—metabolic syndrome X	0.0012	0.0152	CbGeAlD
Ergotamine—Bromocriptine—HTR2C—metabolic syndrome X	0.00117	0.146	CrCbGaD
Ergotamine—ABCB1—blood vessel—metabolic syndrome X	0.00114	0.0145	CbGeAlD
Ergotamine—ADRA1A—adipose tissue—metabolic syndrome X	0.00105	0.0134	CbGeAlD
Ergotamine—ADRA2A—adipose tissue—metabolic syndrome X	0.000802	0.0102	CbGeAlD
Ergotamine—HTR2A—cardiovascular system—metabolic syndrome X	0.000773	0.00986	CbGeAlD
Ergotamine—HTR2A—kidney—metabolic syndrome X	0.000757	0.00964	CbGeAlD
Ergotamine—ADRA1A—liver—metabolic syndrome X	0.00074	0.00943	CbGeAlD
Ergotamine—CYP3A4—kidney—metabolic syndrome X	0.000701	0.00893	CbGeAlD
Ergotamine—CYP1A2—liver—metabolic syndrome X	0.000612	0.0078	CbGeAlD
Ergotamine—ABCB1—cardiovascular system—metabolic syndrome X	0.000507	0.00646	CbGeAlD
Ergotamine—ABCB1—kidney—metabolic syndrome X	0.000496	0.00632	CbGeAlD
Ergotamine—HTR2A—liver—metabolic syndrome X	0.000478	0.0061	CbGeAlD
Ergotamine—ABCB1—adipose tissue—metabolic syndrome X	0.000447	0.0057	CbGeAlD
Ergotamine—CYP3A4—liver—metabolic syndrome X	0.000443	0.00564	CbGeAlD
Ergotamine—ABCB1—liver—metabolic syndrome X	0.000313	0.00399	CbGeAlD
Ergotamine—HTR1D—Signaling Pathways—NOS3—metabolic syndrome X	1.59e-05	0.000111	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	1.59e-05	0.000111	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	1.59e-05	0.000111	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.58e-05	0.00011	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.58e-05	0.00011	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PPARA—metabolic syndrome X	1.57e-05	0.00011	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	1.57e-05	0.00011	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.57e-05	0.00011	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.57e-05	0.00011	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.56e-05	0.000109	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.56e-05	0.000109	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NOS3—metabolic syndrome X	1.56e-05	0.000109	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.56e-05	0.000109	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	1.56e-05	0.000109	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—INS—metabolic syndrome X	1.56e-05	0.000109	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TGFB1—metabolic syndrome X	1.56e-05	0.000109	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CETP—metabolic syndrome X	1.55e-05	0.000109	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AGT—metabolic syndrome X	1.54e-05	0.000108	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.54e-05	0.000107	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCL2—metabolic syndrome X	1.53e-05	0.000107	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AGT—metabolic syndrome X	1.52e-05	0.000106	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	1.52e-05	0.000106	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.52e-05	0.000106	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.52e-05	0.000106	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.52e-05	0.000106	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.52e-05	0.000106	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—APOE—metabolic syndrome X	1.51e-05	0.000106	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—LEP—metabolic syndrome X	1.51e-05	0.000106	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IGF1—metabolic syndrome X	1.51e-05	0.000105	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.5e-05	0.000105	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	1.49e-05	0.000105	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.49e-05	0.000104	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.49e-05	0.000104	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	1.49e-05	0.000104	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.48e-05	0.000103	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	1.47e-05	0.000103	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NOS3—metabolic syndrome X	1.47e-05	0.000103	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.45e-05	0.000101	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	1.44e-05	0.000101	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SERPINE1—metabolic syndrome X	1.43e-05	0.0001	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.42e-05	9.95e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	1.42e-05	9.9e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.41e-05	9.85e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.41e-05	9.83e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.41e-05	9.83e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	1.41e-05	9.82e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.4e-05	9.79e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.39e-05	9.75e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.39e-05	9.75e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.39e-05	9.75e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	1.38e-05	9.67e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.38e-05	9.64e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.37e-05	9.59e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.37e-05	9.59e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.37e-05	9.58e-05	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.37e-05	9.55e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	1.36e-05	9.54e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.36e-05	9.5e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.36e-05	9.48e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.36e-05	9.48e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.35e-05	9.43e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.35e-05	9.43e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	1.35e-05	9.4e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.34e-05	9.39e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.34e-05	9.39e-05	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.34e-05	9.36e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.33e-05	9.33e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.33e-05	9.28e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.33e-05	9.28e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	1.32e-05	9.21e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.31e-05	9.17e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.31e-05	9.13e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.3e-05	9.09e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.29e-05	9.03e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.29e-05	9.02e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOB—metabolic syndrome X	1.29e-05	9.02e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—INS—metabolic syndrome X	1.27e-05	8.91e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.27e-05	8.9e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.27e-05	8.89e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.27e-05	8.86e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.27e-05	8.86e-05	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.26e-05	8.79e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.25e-05	8.77e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.25e-05	8.76e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.25e-05	8.76e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.25e-05	8.75e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.25e-05	8.74e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.25e-05	8.73e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.25e-05	8.73e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.25e-05	8.71e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.24e-05	8.69e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.24e-05	8.69e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.24e-05	8.69e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL6—metabolic syndrome X	1.24e-05	8.69e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.24e-05	8.68e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.24e-05	8.67e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	1.24e-05	8.65e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.24e-05	8.64e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.23e-05	8.63e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	1.23e-05	8.62e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—LPL—metabolic syndrome X	1.23e-05	8.61e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.22e-05	8.56e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	1.21e-05	8.5e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.21e-05	8.48e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.21e-05	8.48e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.2e-05	8.38e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.2e-05	8.38e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.19e-05	8.33e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.19e-05	8.32e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.19e-05	8.3e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.18e-05	8.27e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL6—metabolic syndrome X	1.17e-05	8.2e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.17e-05	8.19e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.17e-05	8.19e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CD36—metabolic syndrome X	1.17e-05	8.18e-05	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.17e-05	8.18e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.17e-05	8.17e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.15e-05	8.06e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.15e-05	8.05e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	1.15e-05	8.05e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.15e-05	8.03e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.15e-05	8.02e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AKT1—metabolic syndrome X	1.15e-05	8.01e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.14e-05	7.98e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.13e-05	7.92e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.13e-05	7.92e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.13e-05	7.89e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.12e-05	7.82e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.11e-05	7.8e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.11e-05	7.78e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.11e-05	7.76e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.09e-05	7.65e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.09e-05	7.6e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.08e-05	7.58e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.08e-05	7.58e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKT1—metabolic syndrome X	1.08e-05	7.56e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.08e-05	7.53e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	1.07e-05	7.45e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.06e-05	7.43e-05	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.06e-05	7.38e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	1.05e-05	7.37e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.05e-05	7.37e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AGT—metabolic syndrome X	1.05e-05	7.36e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	7.33e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	1.04e-05	7.3e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	1.04e-05	7.27e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	1.03e-05	7.22e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOE—metabolic syndrome X	1.03e-05	7.22e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	1.03e-05	7.21e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOB—metabolic syndrome X	1.03e-05	7.2e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	1.03e-05	7.18e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	1.02e-05	7.15e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.02e-05	7.13e-05	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	1.02e-05	7.13e-05	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.01e-05	7.09e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	1.01e-05	7.04e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	1e-05	7.01e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	1e-05	7e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	9.98e-06	6.98e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—LPL—metabolic syndrome X	9.83e-06	6.87e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.79e-06	6.85e-05	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.71e-06	6.79e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	9.7e-06	6.78e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	9.67e-06	6.76e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	9.67e-06	6.76e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	9.59e-06	6.7e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	9.55e-06	6.68e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	9.36e-06	6.55e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	9.36e-06	6.55e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	9.35e-06	6.54e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CD36—metabolic syndrome X	9.34e-06	6.53e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	9.26e-06	6.47e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	9.21e-06	6.44e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	9.02e-06	6.31e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARG—metabolic syndrome X	8.99e-06	6.28e-05	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.95e-06	6.26e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—INS—metabolic syndrome X	8.82e-06	6.16e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.81e-06	6.16e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	8.81e-06	6.16e-05	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.81e-06	6.16e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	8.68e-06	6.07e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.67e-06	6.06e-05	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.62e-06	6.03e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	8.49e-06	5.93e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AGT—metabolic syndrome X	8.41e-06	5.88e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOE—metabolic syndrome X	8.24e-06	5.76e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	8.15e-06	5.7e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	8.14e-06	5.69e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	8.13e-06	5.68e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—metabolic syndrome X	8.08e-06	5.65e-05	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.01e-06	5.6e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	8e-06	5.59e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	7.95e-06	5.56e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.94e-06	5.55e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	7.89e-06	5.51e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	7.87e-06	5.5e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.83e-06	5.47e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.82e-06	5.47e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	7.78e-06	5.44e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—NOS3—metabolic syndrome X	7.73e-06	5.41e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.73e-06	5.4e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LPL—metabolic syndrome X	7.58e-06	5.3e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	7.49e-06	5.24e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	7.33e-06	5.13e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	7.31e-06	5.11e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.27e-06	5.09e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CD36—metabolic syndrome X	7.21e-06	5.04e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	7.18e-06	5.02e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	7.18e-06	5.02e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—metabolic syndrome X	7.07e-06	4.94e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—INS—metabolic syndrome X	7.04e-06	4.92e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	6.91e-06	4.83e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	6.8e-06	4.75e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.79e-06	4.75e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	6.74e-06	4.71e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.7e-06	4.68e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.65e-06	4.65e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AGT—metabolic syndrome X	6.49e-06	4.54e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—metabolic syndrome X	6.45e-06	4.51e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOE—metabolic syndrome X	6.36e-06	4.45e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	6.28e-06	4.39e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	6.27e-06	4.39e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.18e-06	4.32e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	6.17e-06	4.32e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	6.14e-06	4.29e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	5.93e-06	4.14e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.9e-06	4.12e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	5.66e-06	3.96e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	5.64e-06	3.95e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	5.64e-06	3.95e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.54e-06	3.87e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	5.47e-06	3.82e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.44e-06	3.8e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—INS—metabolic syndrome X	5.43e-06	3.8e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	5.21e-06	3.64e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	5.2e-06	3.64e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	5.14e-06	3.59e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	5.12e-06	3.58e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	5.01e-06	3.51e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.98e-06	3.48e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.8e-06	3.36e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.76e-06	3.33e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.72e-06	3.3e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.66e-06	3.26e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.63e-06	3.23e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.36e-06	3.05e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4.3e-06	3e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AKT1—metabolic syndrome X	3.55e-06	2.48e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.84e-06	1.98e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.19e-06	1.53e-05	CbGpPWpGaD
